Stock screener

RMD

Conviction 53HealthcareScan · Tue, Sep 8, 2026
Bearish engulfing
RMD$221.06-3.19%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 1.39M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
RESMED INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.resmed.com
Price221.06
Change-3.19%
Gap+0.24%
Rel volume1.19×
Avg volume1.36M
Avg $ vol312.58M
SMA 20229.74
SMA 50215.70
SMA 200228.26
Price vs 50+2.49%
Price vs 200-3.16%
MA stackmixed
50/200 cross
Supertrendup · 219.73
RSI (14)45
MACD hist-1.97
MACD crossbear · 3d
Stoch %K / %D3 / 28
ADX (14)19
+DI / −DI20 / 24
RSI divergence
MACD divergenceBearish
ATR %+3.07%
ADR %2.76%
52w high283.28
52w low182.82
From 52w high-21.96%
Above 52w low+20.92%
New 52w highNo
SqueezeOff
Bollinger width10.23%
%B0.13
Donchian pos20.04%
Donchian high242.40
Donchian low215.71
AVWAP (52w high)228.64
vs AVWAP high-3.31%
AVWAP (52w low)209.28
vs AVWAP low+5.63%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d1.19×
Avg vol (14d)1.39M
Avg vol (20d)1.36M
Avg $ vol (20d)312.58M
Market cap31.89B
RS 3m (vs SPY)+12.06%
RS 6m (vs SPY)-24.24%
RS line new highNo
Trend template3/8
Technical rank37.1
1 week-7.93%
1 month+4.30%
3 months+14.46%
6 months-12.60%
1 year-20.21%
YTD-9.70%
P/E20.93
P/B4.84
P/S5.64
P/FCF19.33
EPS10.43
Div yield1.10%
ROE23.13%
ROA16.99%
Debt/Eq0.15
Current3.10
EV/EBITDA15.06
Gross margin61.06%
Net margin26.94%
Rev growth9.85%
EPS growth8.75%
Price target239.50
Target upside8.34%
Analyst ratingHold
Institutional82.41%
Ent. value31.44B
Revenue1.43B
Net income398.73M
Gross profit890.98M
Free cash flow1.65B
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out145.06M
Employees10.6K
ListedFri, Jun 2, 1995
Free float144.48M
Float %99.2%
Short interest12.79M
Days to cover7.4d
Short volume89.0%
Squeeze score65 / 100
Next earnings
EPS forecast
Last EPS vs est$2.95 vs $2.90
Last surprise+1.7% beat
Setup gradeC
Conviction53 / 100
Pattern quality
Tech rank37.1 / 100
Group rank96 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RMD · 6 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Kelly Louise Morrison
Kelly Louise Morrison
house · D · MN · traded 2025-06-04
Sell$1K–$15K
Kelly Louise Morrison
Kelly Louise Morrison
house · D · MN · traded 2025-04-28
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-01-13
Sell$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in RMD · 3 buys · 6 sells

InsiderSideShares
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-08-07
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-08-07
Sell4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock Options · 2026-08-07
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-07-07
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-07-07
Sell4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock Options · 2026-07-07
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-06-08
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-06-08
Sell4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock Options · 2026-06-08
Exercise4.99K
Farrell Michael J.
Chairman and CEO · ResMed Common Stock · 2026-06-08
Other

SEC filings

EDGAR filings in RMD · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.